Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

Documenti analoghi

• Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial
  di: Payne, H, et al.
  Pubblicazione: (2015)
• Naive B Cell Output in HIV-Infected and HIV-Uninfected Children
  di: Payne, Helen, et al.
  Pubblicazione: (2019)
• Early limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) Randomized Trial
  di: Cotton, Mark F, et al.
  Pubblicazione: (2013)
• Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis
  di: Rabie, H., et al.
  Pubblicazione: (2011)
• Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
  di: Laughton, Barbara, et al.
  Pubblicazione: (2018)